EN
HI
Concord Drugs Share price
CONCORD
65
1.46 (-2.20%)Last updated on 15 Oct, 2025 | 14:41 IST
BUYSELL
Today's High
68.45
Today's Low
63.14
52 Week Low
26.10
52 Week High
71.25
The current prices are delayed, login to your account for live prices
LoginConcord Drugs Share Key Metrics
Volume
2737.00
Market Cap
66.46 CR
LTQ@LTP
170@65.00
ATP
65.21
Var Margin
100 %
Circuit Range
63.14-69.78
Delivery %
0 %
Value
1.78 L
ASM/GSM
No
Market Lot
1
Concord Drugs Fundamentals
View MoreP/E Ratio
155.64
P/B Ratio
1.94
Div. Yield
0
Sector P/E
37.49
Sector P/B
3.56
Sec. Div. Yield
0.55
Concord Drugs Resistance and Support
Pivot 30.52
Resistance
First Resistance
31.04
Second Resistance
31.31
Third Resistance
31.83
Support
First Support
30.25
Second Support
29.73
Third Support
29.46
Concord Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2025-08-08 | Quarterly Results |
| 2025-07-03 | Preferential issue of shares |
| 2025-06-27 | Preferential Issue of shares & Others |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
| 2025-03-13 | Preferential Issue of shares & Others |
| 2025-01-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Drugs News
BRIEF-Concord Drugs Says Approved Sale Of Non-Agricultural/Industrial Land, Ground, With Structures In Uttarakhand State
Oct 13 2020 19:21:03
Read More
About Concord Drugs
NSE : 0
BSE : 538965
ISIN : INE858L01010
CONCORD DRUGS LIMITED a company with its registered office at 5-9-22/36 Adarsha Nagar Hyderabad - 500463 (With effect from 14196 as for resolution dated 1.4.96 Change of Registered Office is being file with ROC was incorporated as a public limited company on 24th April 1995. The factory of the company is situated at survey No.s 248-251 Torruru Village Brahmanapally post Hyathnagar mandal R.R.Dist. Andhra Pradesh. The main objects of the company is to carry on the business of manufacturing and selling of pharmaceuticals formulations i.e. Tablets Capsules Liquids and Sterile Powder Injections Bio Adhesive and Radio Opec agent.SUBSIDIARIES OF THE COMPANYThe company has no subsidiary.
Concord Drugs Management
| Name | Position |
|---|---|
| Mr. S Nagi Reddy | Chairman & Managing Director |
| Mr. S Manoj Kumar Reddy | Whole Time Director |
Concord Drugs Similar Stocks
Vista Pharmaceuticals Ltd.
9.78
0.21 (2.19%)
Shelter Pharma Ltd.
41.96
0.36 (0.87%)
iStreet Network Ltd.
36.49
3.38 (10.21%)
Aspira Pathlab & Diagnostics Ltd.
65.50
0.36 (0.55%)
NG Industries Ltd.
143.85
2.80 (1.99%)
Vineet Laboratories Ltd.
40.50
-1.25 (2.99%)
Centenial Surgical Suture Ltd.
104.90
5.40 (5.43%)
Amkay Products Ltd.
43.00
-2.00 (4.44%)
Chandra Bhagat Pharma Ltd.
43.00
0.00 (0.00%)
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 155.64. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 1.94. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 37.49 & 3.56 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 66.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 71.25 & 26.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Drugs belongs to the Healthcare sector.